[HTML][HTML] Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

A Fabra-García, S Hailemariam, RM de Jong… - Immunity, 2023 - cell.com
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …

[HTML][HTML] Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

A Fabra-García, S Hailemariam, RM de Jong… - Immunity, 2023 - cell.com
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

A Fabra-García, S Hailemariam, RM de Jong… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …

[PDF][PDF] Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

A Fabra-Garcıa, S Hailemariam, RM de Jong… - …, 2023 - media.malariaworld.org
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …

[PDF][PDF] Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes.

A Fabra García, S Hailemariam, RM de Jong… - 2023 - repository.ubn.ru.nl
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes.

A Fabra-García, S Hailemariam, RM de Jong… - Immunity, 2023 - europepmc.org
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …

[HTML][HTML] Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

A Fabra-García, S Hailemariam, RM de Jong… - Immunity, 2023 - Elsevier
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …

[HTML][HTML] Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

A Fabra-García, S Hailemariam, RM de Jong… - Immunity, 2023 - ncbi.nlm.nih.gov
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes

A Fabra-García, S Hailemariam, RM de Jong… - paper.sciencenet.cn
Malaria transmission-blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …

Highly Potent Naturally Acquired Human Monoclonal Antibodies Against Pfs48/45 Block Plasmodium falciparum Transmission to Mosquitoes

A Fabra-Garcia, S Hailemariam, R de Jong, K Janssen… - papers.ssrn.com
Malaria transmission blocking vaccines (TBVs) aim to induce antibodies that interrupt
malaria parasite development in the mosquito, thereby blocking onward transmission, and …